Nevos

Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. J Am Acad Dermatol. 2012 Jul;67(1):1.e1-16. Resumo

Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era. Part II. Molecular aspects and clinical management. J Am Acad Dermatol. 2012 Jul;67(1):19.e1-12. Resumo

Wernli KJ, Henrikson NB, Morrison CC, et al. Screening for skin cancer in adults: updated evidence report and systematic review for the US preventive services task force. JAMA. 2016 Jul 26;316(4):436-47.Texto completo  Resumo

1. McKee PH, Calonje E, Granter SR, eds. Pathology of the skin. 3rd ed. London: Elsevier; 2005.

2. Argenziano G, Zalaudek I, Ferrara G, et al. Proposal of a new classification system for melanocytic naevi. Br J Dermatol. 2007 Aug;157(2):217-27. Resumo

3. Schmoeckel, C. Classification of melanocytic nevi: do nodular and flat nevi develop differently? Am J Dermatopathol. 1997 Feb;19(1):31-4. Resumo

4. Burkhart CG. Dysplastic nevi. N Engl J Med. 2004 Mar 18;350(12):1258-9. Resumo

5. Bolognia JL, Jorizzo JL, Rapini RP, et al. Dermatology. 2nd ed. New York, NY: Mosby; 2008.

6. Tannous ZS, Mihm MC Jr, Sober AJ, et al. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol. 2005 Feb;52(2):197-203. Resumo

7. Schaffer JV. Pigmented lesions in children: when to worry. Curr Opin Pediatr. 2007 Aug;19(4):430-40. Resumo

8. Elder DE, Massi D, Scolyer RA, et al, eds. WHO classification of skin tumours. 4th ed. Lyon, France: International Agency for Research on Cancer; 2018.

9. Mesbah Ardakani N. Dysplastic/Clark naevus in the era of molecular pathology. Australas J Dermatol. 2019 Aug;60(3):186-91. Resumo

10. Sarin KY, Sun BK, Bangs CD, et al. Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus. JAMA Dermatol. 2013 Sep;149(9):1077-81.Texto completo  Resumo

11. Elder DE, Bastian BC, Cree IA, et al. The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma: detailed analysis of 9 distinct subtypes defined by their evolutionary pathway. Arch Pathol Lab Med. 2020 Apr;144(4):500-22.Texto completo  Resumo

12. Dulon M, Weichenthal M, Blettner M, et al. Sun exposure and number of nevi in 5- to 6- year-old European children. J Clin Epidemiol. 2002 Nov;55(11):1075-81. Resumo

13. Maize JC, Foster G. Age-related changes in melanocytic naevi. Clin Exp Dermatol. 1979 Mar;4(1):49-58. Resumo

14. Coleman WP 3rd, Gately LE 3rd, Krementz AB, et al. Nevi, lentigines, and melanoma in blacks. Arch Dermatol. 1980 May;116(5):548-51. Resumo

15. Gallagher RP, Rivers JK, Lee TK, et al. Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial. JAMA. 2000 Jun 14;283(22):2955-60.Texto completo  Resumo

16. Warner PM, Yakuboff KP, Kagan RJ, et al. An 18-year experience in the management of congenital nevomelanocytic nevi. Ann Plast Surg. 2008 Mar;60(3):283-7. Resumo

17. Ackerman AB. "Dysplastic nevus" syndrome: does a survey make it real? J Am Acad Dermatol. 2003 Mar;48(3):461-3. Resumo

18. Valiukeviciene S, Miseviciene I, Gollnick H. The prevalence of common acquired melanocytic nevi and the relationship with skin type characteristics and sun exposure among children in Lithuania. Arch Dermatol. 2005 May;141(5):579-86. Resumo

19. Wachsmuth RC, Turner F, Barrett JH, et al. The effect of sun exposure in determining nevus density in UK adolescent twins. J Invest Dermatol. 2005 Jan;124(1):56-62. Resumo

20. Rivers JK, Maclennan R, Kelly JW, et al. The eastern Australian childhood nevus study: prevalence of atypical nevi, congenital nevus-like nevi, and other pigmented lesions. J Am Acad Dermatol. 1995 Jun;32(6):957-63. Resumo

21. Gallagher RP, McLean DI. The epidemiology of acquired melanocytic nevi: a brief review. Dermatol Clin. 1995 Jul;13(3):595-603. Resumo

22. Grichnik JM. Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol. 2008 Oct;128(10):2365-80. Resumo

23. Burkhart CG, Burkhart CN. The mole theory: primary function of melanocytes and melanin may be antimicrobial defense and immunomodulation (not solar protection). Int J Dermatol. 2005 Apr;44(4):340-2. Resumo

24. Koh HK. Cutaneous melanoma. N Engl J Med. 1991 Jul 18;325(3):171-82. Resumo

25. Harrison SL, MacLennan R, Buettner PG. Sun exposure and the incidence of melanocytic nevi in young Australian children. Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2318-24. Resumo

26. Kelly JW, Rivers JK, MacLennan R, et al. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol. 1994 Jan;30(1):40-8. Resumo

27. American Academy of Dermatology. Body mole map. 2022 [internet publication].Texto completo

28. American Melanoma Foundation. ABCD's of melanoma. 2006 [internet publication].Texto completo

29. Schaffer JV, Orlow SJ, Lazova R, et al. Speckled lentiginous nevus: within the spectrum of congenital melanocytic nevi. Arch Dermatol. 2001 Feb;137(2):172-8.Texto completo  Resumo

30. Cyr PR. Atypical moles. Am Fam Physician. 2008 Sep 15;78(6):735-40. Resumo

31. Larsen F, Cockerell CJ. The dysplastic nevus concept. Pathology Case Rev. 2007 Nov/Dec;12(6):240-4.

32. Salopek TG. The dilemma of the dysplastic nevus. Dermatol Clin. 2002 Oct;20(4):617-28. Resumo

33. Grob JJ, Bonerandi JJ. The ugly duckling sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. Arch Dermatol. 1998 Jan;134(1):103-4. Resumo

34. Zhang AJ, Rush PS, Tsao H, et al. BRCA1-associated protein (BAP1)-inactivated melanocytic tumors. J Cutan Pathol. 2019 Dec;46(12):965-72.Texto completo  Resumo

35. Yeh I, Lang UE, Durieux E, et al. Combined activation of MAP kinase pathway and β-catenin signaling cause deep penetrating nevi. Nat Commun. 2017 Sep 21;8(1):644.Texto completo  Resumo

36. Mandal RV, Murali R, Lundquist KF, et al. Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up. Am J Surg Pathol. 2009 Dec;33(12):1778-82. Resumo

37. Campos-do-Carmo G, Ramos-e-Silva M. Dermatoscopy: basic concepts. Int J Dermatol. 2008 Jul;47(7):712-9. Resumo

38. Tschandl P, Rosendahl C, Kittler H. The HAM10000 dataset, a large collection of multi-source dermatoscopic images of common pigmented skin lesions. Sci Data. 2018 Aug 14;5:180161.Texto completo  Resumo

39. Smith L, Macneil S. State of the art in non-invasive imaging of cutaneous melanoma. Skin Res Technol. 2011 Aug;17(3):257-69.Texto completo  Resumo

40. Brehmer F, Ulrich M, Haenssle HA. Strategies for early recognition of cutaneous melanoma - present and future. Dermatol Pract Conc. 2012 Jul 31;2(3):203a06.Texto completo  Resumo

41. Walter FM, Morris HC, Humphrys E, et al. Protocol for the MoleMate UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379]. BMC Fam Pract. 2010 May 11;11:36.Texto completo  Resumo

42. Moncrieff M, Cotton S, Claridge E, et al. Spectrophotometric intracutaenous analysis: a new technique for imagining pigmented skin lesions. Br J Dermatol. 2002 Mar;146(3):448-57. Resumo

43. Mackie RM, Doherty VR. Seven-point checklist for melanoma. Clin Exp Dermatol. 1991 Mar;16(2):151-3. Resumo

44. Walter FM, Morris HC, Humphrys E, et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ. 2012 Jul 4;345:e4110.Texto completo  Resumo

45. Elbaum M, Kopf AW, Rabinovitz HS, et al. Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol. 2001 Feb;44(2):207-18. Resumo

46. Bolognia JL. Biopsy techniques for pigmented lesions. Dermatol Surg. 2000 Jan;26(1):89-90. Resumo

47. Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. J Am Acad Dermatol. 2012 Jul;67(1):1.e1-16. Resumo

48. Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era. Part II. Molecular aspects and clinical management. J Am Acad Dermatol. 2012 Jul;67(1):19.e1-12. Resumo

49. Arneja JS, Gosain AK. Giant congenital melanocytic nevi. Plast Reconstr Surg. 2009 Jul;124(1 Suppl):1e-13e. Resumo

50. Marghoob AA, Kopf AW. Persistent nevus: an exception to the ABCD rule of dermoscopy. J Am Acad Dermatol. 1997 Mar;36(3 Pt 1):474-5. Resumo

51. Kornber R, Ackerman AB. Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal. Arch Dermatol. 1975 Dec;111(12):1588-90. Resumo

52. New Zealand Guidelines Group. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. Jun 2008 [internet publication].Texto completo

53. Strazzula L, Vedak P, Hoang MP, et al. The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis. J Am Acad Dermatol. 2014 Dec;71(6):1071-6. Resumo

54. Reddy KK, Farber MJ, Bhawan J, et al. Atypical (dysplastic) nevi: outcomes of surgical excision and association with melanoma. JAMA Dermatol. 2013 Aug;149(8):928-34.Texto completo  Resumo

55. Abello-Poblete MV, Correa-Selm LM, Giambrone D, et al. Histologic outcomes of excised moderate and severe dysplastic nevi. Dermatol Surg. 2014 Jan;40(1):40-5. Resumo

56. Kim CC, Berry EG, Marchetti MA, et al. Risk of subsequent cutaneous melanoma in moderately dysplastic nevi excisionally biopsied but with positive histologic margins. JAMA Dermatol. 2018 Dec 1;154(12):1401-8. Resumo

57. Kim CC, Swetter SM, Curiel-Lewandrowski C, et al. Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi: Pigmented Lesion Subcommittee consensus statement. JAMA Dermatol. 2015 Feb;151(2):212-8. Resumo

58. Elmore JG, Barnhill RL, Elder DE, et al. Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study. BMJ. 2017 Jun 28;357:j2813.Texto completo  Resumo

59. Ferris LK, Jansen B, Ho J, et al. Utility of a noninvasive 2-gene molecular assay for cutaneous melanoma and effect on the decision to biopsy. JAMA Dermatol. 2017 Jul 1;153(7):675-80.Texto completo  Resumo

60. Ko JS, Matharoo-Ball B, Billings SD, et al. Diagnostic distinction of malignant melanoma and benign nevi by a gene expression signature and correlation to clinical outcomes. Cancer Epidemiol Biomarkers Prev. 2017 Apr 4;26(7):1107-13.Texto completo  Resumo

61. Gerami P, Scolyer RA, Xu X, et al. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol. 2013 May;37(5):676-84. Resumo

62. Gerami P, Li G, Pouryazdanparast P, et al. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Am J Surg Pathol. 2012 Jun;36(6):808-17. Resumo

63. Lezcano C, Jungbluth AA, Nehal KS, et al. PRAME expression in melanocytic tumors. Am J Surg Pathol. 2018 Nov;42(11):1456-65.Texto completo  Resumo

64. Colebatch AJ, Ferguson P, Newell F, et al. Molecular genomic profiling of melanocytic nevi. J Invest Dermatol. 2019 Aug;139(8):1762-8.Texto completo  Resumo

65. Ostendorf W. Preparation for safe medication administration. In: Perry AG, Potter PA, Elkin MK, eds. Nursing interventions & clinical skills. 7th ed. St Louis, MO: Mosby; 2020.

66. WHO Best Practices for Injections and Related Procedures Toolkit. Geneva: World Health Organization; 2010 Mar. Resumo

67. Jin JF, Zhu LL, Chen M, et al. The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection. Patient Prefer Adherence. 2015;9:923-42.Texto completo  Resumo

68. Tanaka M. Dermoscopy. J Dermatol. 2006 Aug;33(8):513-7. Resumo

69. Zalaudek I, Docimo G, Argenziano G. Using dermoscopic criteria and patient-related factors for the management of pigmented melanocytic nevi. Arch Dermatol. 2009 Jul;145(7):816-26.Texto completo  Resumo

70. American Cancer Society. Cancer facts and figures 2022. 2022 [internet publication].Texto completo

71. Rigel DS. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J Am Acad Dermatol. 2008 May;58(5 Suppl 2):S129-32. Resumo

72. Olsen CM, Carroll HJ, Whiteman DC. Estimating the attributable fraction for cancer: a meta-analysis of nevi and melanoma. Cancer Prev Res (Phila). 2010 Feb;3(2):233-45. Resumo

73. US Preventive Services Task Force. Skin cancer prevention: behavioral counseling. Mar 2018 [internet publication].Texto completo

74. US Preventive Services Task Force. Final recommendation statement. Skin cancer: screening. Apr 2023 [internet publication].Texto completo  Resumo

75. Smack DP, Harrington AC, Dunn C, et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment. A randomized controlled trial. JAMA. 1996 Sep 25;276(12):972-7. Resumo

76. Campbell RM, Perlis CS, Fisher E, et al. Gentamicin ointment versus petrolatum for management of auricular wounds. Dermatol Surg. 2005 Jun;31(6):664-9. Resumo

77. Gette MT, Marks JG Jr, Maloney ME. Frequency of postoperative allergic contact dermatitis to topical antibiotics. Arch Dermatol. 1992 Mar;128(3):365-7. Resumo

78. Suzuki H, Anderson RR. Treatment of melanocytic nevi. Dermatol Ther. 2005 May-Jun;18(3):217-26. Resumo

79. Polder KD, Landau JM, Vergilis-Kalner IJ, et al. Laser eradication of pigmented lesions: a review. Dermatol Surg. 2011 May;37(5):572-95. Resumo

80. Lee PK, Rosenberg CN, Tsao H, et al. Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases. J Am Acad Dermatol. 1998 Feb;38(2 Pt 2):314-7. Resumo

81. Gottschaller C, Hohenleutner U, Landthaler M. Metastasis of a malignant melanoma 2 years after carbon dioxide laser treatment of a pigmented lesion: case report and review of the literature. Acta Derm Venereol. 2006;86(1):44-7.Texto completo  Resumo

82. Woodrow SL, Burrows SN. Malignant melanoma occurring at the periphery of a giant congenital naevus preciously treated with laser therapy. Br J Dermatol. 2003 Oct;149(4):886-8. Resumo

83. Dummer R, Kempf W, Burg G. Pseudo-melanoma after laser therapy. Dermatology. 1998;197(1):71-3. Resumo

84. Elder DE, Elenitsas R, Johnson BL, eds. Lever's histopathology of the skin. 10th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2009.

85. Cancer Research UK. Skin cancer statistics - key facts. May 2012 [internet publication].Texto completo

86. Herzog C, Pappo A, Bondy M, et al. Malignant melanoma. In: Bleyer A, O'Leary M, Barr R, et al, eds. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. Bethesda, MD: National Cancer Institute; 2006:53-64.Texto completo

87. Vourc'h-Jourdain M, Martin L, Barbarot S; aRED. Large congenital melanocytic nevi: therapeutic management and melanoma risk: a systematic review. J Am Acad Dermatol. 2013 Mar;68(3):493-8.e1-14. Resumo

88. Barnhill RL, Flotte TJ, Fleischli M, et al. Cutaneous melanoma and atypical Spitz tumors in childhood. Cancer. 1995 Nov 15;76(10):1833-45. Resumo

89. Cerrato F, Wallins JS, Webb ML, et al. Outcomes in pediatric atypical Spitz tumors treated without sentinel lymph node biopsy. Pediatr Dermatol. 2011 Dec 30;29(4):448-53. Resumo

90. Lee CY, Sholl LM, Zhang B, et al. Atypical spitzoid neoplasms in childhood: a molecular and outcome study. Am J Dermatopathol. 2017 Mar;39(3):181-6. Resumo

91. Massi D, Tomasini C, Senetta R, et al. Atypical Spitz tumors in patients younger than 18 years. J Am Acad Dermatol. 2014 Oct 25;72(1):37-46. Resumo

92. Kanzler MH, Mraz-Gernhard S. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview. J Am Acad Dermatol. 2001 Aug;45(2):260-76. Resumo

93. Clark WH Jr, Reimer RR, Greene M, et al. Origin of familial malignant melanomas from heritable melanocytic lesions: 'the B-K mole syndrome'. Arch Dermatol. 1978 May;114(5):732-8. Resumo

94. Tsao H, Sober AJ, Niendorf KB, et al. Case records of the Massachusetts General Hospital: a 48-year-old woman with multiple pigmented lesions and a personal and family history of melanoma. N Engl J Med. 2004 Feb 26;350(9):924-32. Resumo

95. de Maleissye MF, Beauchet A, Saiag P, et al. Sunscreen use and melanocytic nevi in children: a systematic review. Pediatr Dermatol. 2013 Jan-Feb;30(1):51-9. Resumo

96. Crane LA, Deas A, Mokrohisky ST, et al. A randomized intervention study of sun protection promotion in well-child care. Prev Med. 2006 Mar;42(3):162-70. Resumo

97. Menzies SW. Is sun exposure a major cause of melanoma? Yes. BMJ. 2008 Jul 22;337:a763. Resumo

98. Eide MJ, Weinstock MA. Association of UV index, latitude, and melanoma incidence in nonwhite populations - US surveillance, epidemiology, and end results (SEER) program, 1992 to 2001. Arch Dermatol. 2005 Apr;141(4):477-81.Texto completo  Resumo

99. Shuster S. Is sun exposure a major cause of melanoma? No. BMJ. 2008 Jul 22;337:a764. Resumo

100. Wernli KJ, Henrikson NB, Morrison CC, et al. Screening for skin cancer in adults: updated evidence report and systematic review for the US preventive services task force. JAMA. 2016 Jul 26;316(4):436-47.Texto completo  Resumo